Join
Live feed
·
PRReleasevia Quantisnow
InMed Pharmaceuticals Inc. logo

Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline

ByQuantisnow·Wall Street's wire, on your screen.
INM· InMed Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INM (InMed Pharmaceuticals Inc.) and more on Quantisnow.